Thalidomide and Venous Thrombosis

  1. B. Escudier, MD;
  2. N. Lassau, MD;
  3. S. Leborgne, MD, PhD;
  4. E. Angevin; and
  5. A. Laplanche, MD
  1. Institut Gustave Roussy 94805 Villejuif, France

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been …

    « Previous | Next Article »Table of Contents